The adverse effects associated with febuxostat therapy include nausea, diarrhea, arthralgia, headache, increased hepatic serum enzyme levels and rash.<ref name=label>[http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021856lbl.pdf Uloric label]  Updated February, 2009.</ref><ref name=Love>{{cite journal | doi = 10.1592/phco.30.6.594 |vauthors=Love BL, Barrons R, Veverka A, Snider KM | title = Urate-lowering therapy for gout: focus on febuxostat | journal = Pharmacotherapy | volume = 30 | issue = 6 | pages = 594â€“608 | year = 2010 | pmid = 20500048}}</ref>

 

